The Futures Program, jointly run by PALTmed and the Foundation for Post-Acute and Long-Term Care (PALTC) Medicine, was created to introduce residents, fellows, advanced practice providers, and allied health professionals to a career in PALTC medicine. Since its inception in 2001, more than 1,500 individual...
Motoric cognitive risk (MCR) syndrome signals dementia risk in older adults, with social relationships recognized as modifiable influences; however, their interconnectedness with the multilayer factors of the health ecology model remains underexplored. This study aims to investigate the central and bridgin...
The Centers for Medicare and Medicaid Services Polypharmacy-CNS (Poly-CNS) quality metric identifies individuals taking multiple medications with central nervous system side effects. The Poly-CNS measure may reduce risky prescribing for persons living with dementia (PLWD).
Most studies assessing the effect of central nervous system (CNS)-acting medicines on cognitive disturbances have focused on the use of individual medicines. The impact on cognitive function when another CNS-acting medicine is added to a patient's treatment regimen is not well known.